We are a leading bio-technology company focused on the development and marketing of novel diagnostic products through the analysis of proteins. We believe that the future of medicine will shift from a treatment paradigm to a prevention paradigm. By understanding the proteins in a disease, we believe that individuals with a greater risk of developing a specific disease can be identified. Physicians can use this information to improve patient outcomes and identify those individuals who would benefit from preventive therapies. We employ a number of proprietary technologies that help us to understand the genetic basis of human disease and the role that proteins play in the onset, progression and treatment of disease. We use this information to develop diagnostic products that are designed to assess an individual’s risk for developing disease (predictive medicine), an individual’s response to drug therapy (personalized medicine), and an individual’s risk of disease progression and disease recurrence (prognostic medicine). Our goal is to provide physicians with critical information to guide the management of their patients to prevent disease, delay the onset of disease, or catch the disease at an earlier, treatable stage.
Company profile
Ticker
PWRM
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Syneos Health • Icon • Medpace • Incyte • Zymergen • OmniAb ...
Former names
Surgical Safety Products Inc
SEC CIK
Corporate docs
IRS number
650565144
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
18 Dec 14
10-Q
2011 Q3
Quarterly report
18 Nov 11
NT 10-Q
Notice of late quarterly filing
15 Nov 11
10-Q
2011 Q2
Quarterly report
23 Aug 11
NT 10-Q
Notice of late quarterly filing
16 Aug 11
10-Q
2011 Q1
Quarterly report
16 May 11
10-K
2010 FY
Annual report
5 May 11
NT 10-K
Notice of late annual filing
1 Apr 11
S-8
Registration of securities for employees
28 Feb 11
Latest ownership filings
No filings